<DOC>
	<DOCNO>NCT01425320</DOCNO>
	<brief_summary>This study investigate pharmacokinetics , safety tolerability dapsone adapalene follow topical administration 2 formulation dapsone/adapalene fix combination gel , dapsone 5 % gel ( ACZONE® ) , adapalene 0.3 % gel ( Differin® ) subject acne vulgaris .</brief_summary>
	<brief_title>Pharmacokinetics Study Dapsone-Adapalene Fixed Combination Gel Acne</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<criteria>Moderate acne face Willing avoid swimming study Willing avoid excessive sunlight ultraviolet light ( e.g. , tan bed ) study Willing avoid moisturizers , sunscreen , cosmetic , chemical peel study Severe cystic acne Use topical oral retinoids within 4 week Use isotretinoin within 3 month Use dapsone adapalene within 3 month Anticipated need engage activities/exercise would cause profuse sweat Donated blood equivalent blood loss within 90 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>